Oncternal Therapeutics to Provide Business Update and Report Third Quarter 2022 Financial Results
SAN DIEGO, Oct. 27, 2022 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
SAN DIEGO, Oct. 27, 2022 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
REYKJAVIK, Iceland, Oct. 27, 2022 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company…
Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar…
NEW YORK, Oct. 27, 2022 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS),…
DURHAM, N.C., Oct. 27, 2022 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is…
JUPITER, Fla., Oct. 27, 2022 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”,…
NEW YORK, Oct. 27, 2022 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a…
Conference Call and Webcast to be Held at 8:00 AM ET / 2:00 PM CET…
CAMBRIDGE, Mass., Oct. 27, 2022 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage…
ENCINITAS, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX), (“Ventyx”), a…
REDWOOD CITY, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a…
SANTA MONICA, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant” or “Company”) (NASDAQ:…
BELTSVILLE, Md., Oct. 27, 2022 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical…
Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT…
LAKE FOREST, Ill., Oct. 27, 2022 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
SAN DIEGO and TAICANG, SUZHOU, China, Oct. 27, 2022 (GLOBE NEWSWIRE) — Connect Biopharma Holdings…
Sagard Healthcare Partners Acquires Rights to Agios’ 5% Royalty on TIBSOVO® U.S. Net Sales CAMBRIDGE,…
EMA accepted for review the Conditional Marketing Authorization application for sparsentan for IgAN in Europe;…
NEWS RELEASE – REGULATED INFORMATION27 OCTOBER 2022, 4:00PM EDT / 22:00 CET MDxHealth Reports Q3-2022…
Jacob Avidar Joins as VP of Engineering Along with Shane Marzola as VP of Business…